As of early September 2026, the CDC has confirmed 3,134 measles cases year-to-date through September 3, with 95% linked to ongoing outbreaks across 47 jurisdictions and 94% occurring in unvaccinated individuals or those with unknown status. Primary drivers of continued transmission include sustained local chains in states such as Pennsylvania (over 550 cases), Utah, South Carolina, and Texas, fueled by declining MMR vaccination coverage. Official surveillance shows 8% hospitalization rates, while model projections and historical patterns indicate additional cases will accrue through September 30 amid weekly CDC reporting cycles and variable state-level detection. Traders should monitor forthcoming CDC updates for any shifts in confirmed counts or outbreak declarations, as underreporting and diagnostic delays introduce uncertainty around final totals.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedMeasles cases in U.S. by September 30?
Measles cases in U.S. by September 30?
NEW
Sep 30, 2026
3200+
99%
3300+
97%
3400+
93%
3500+
87%
$5,946 Vol.
3200+
$1,847 Vol.
99%
3300+
$172 Vol.
97%
3400+
$0 Vol.
93%
3500+
$299 Vol.
87%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the CDC has confirmed 3,134 measles cases year-to-date through September 3, with 95% linked to ongoing outbreaks across 47 jurisdictions and 94% occurring in unvaccinated individuals or those with unknown status. Primary drivers of continued transmission include sustained local chains in states such as Pennsylvania (over 550 cases), Utah, South Carolina, and Texas, fueled by declining MMR vaccination coverage. Official surveillance shows 8% hospitalization rates, while model projections and historical patterns indicate additional cases will accrue through September 30 amid weekly CDC reporting cycles and variable state-level detection. Traders should monitor forthcoming CDC updates for any shifts in confirmed counts or outbreak declarations, as underreporting and diagnostic delays introduce uncertainty around final totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Market Opened: Sep 1, 2026, 4:19 PM ET
Volume
$5,946End Date
Oct 1, 2026Market Opened
Sep 1, 2026, 4:19 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the CDC has confirmed 3,134 measles cases year-to-date through September 3, with 95% linked to ongoing outbreaks across 47 jurisdictions and 94% occurring in unvaccinated individuals or those with unknown status. Primary drivers of continued transmission include sustained local chains in states such as Pennsylvania (over 550 cases), Utah, South Carolina, and Texas, fueled by declining MMR vaccination coverage. Official surveillance shows 8% hospitalization rates, while model projections and historical patterns indicate additional cases will accrue through September 30 amid weekly CDC reporting cycles and variable state-level detection. Traders should monitor forthcoming CDC updates for any shifts in confirmed counts or outbreak declarations, as underreporting and diagnostic delays introduce uncertainty around final totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$5,946End Date
Oct 1, 2026Market Opened
Sep 1, 2026, 4:19 PM ETResolver
0x65070BE91...As of early September 2026, the CDC has confirmed 3,134 measles cases year-to-date through September 3, with 95% linked to ongoing outbreaks across 47 jurisdictions and 94% occurring in unvaccinated individuals or those with unknown status. Primary drivers of continued transmission include sustained local chains in states such as Pennsylvania (over 550 cases), Utah, South Carolina, and Texas, fueled by declining MMR vaccination coverage. Official surveillance shows 8% hospitalization rates, while model projections and historical patterns indicate additional cases will accrue through September 30 amid weekly CDC reporting cycles and variable state-level detection. Traders should monitor forthcoming CDC updates for any shifts in confirmed counts or outbreak declarations, as underreporting and diagnostic delays introduce uncertainty around final totals.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions